Marcel Verheij

20.1k total citations · 5 hit papers
252 papers, 13.3k citations indexed

About

Marcel Verheij is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Marcel Verheij has authored 252 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Pulmonary and Respiratory Medicine, 78 papers in Molecular Biology and 70 papers in Oncology. Recurrent topics in Marcel Verheij's work include Gastric Cancer Management and Outcomes (70 papers), Metastasis and carcinoma case studies (42 papers) and Gastrointestinal Tumor Research and Treatment (28 papers). Marcel Verheij is often cited by papers focused on Gastric Cancer Management and Outcomes (70 papers), Metastasis and carcinoma case studies (42 papers) and Gastrointestinal Tumor Research and Treatment (28 papers). Marcel Verheij collaborates with scholars based in Netherlands, United States and United Kingdom. Marcel Verheij's co-authors include Andrés Cervantes, David Cunningham, William Allum, Wim J. van Blitterswijk, Harry Bartelink, Adriana Haimovitz‐Friedman, Dirk Arnold, Richard Kolesnick, Ron Bose and Alicia Okines and has published in prestigious journals such as Nature, Cell and Nucleic Acids Research.

In The Last Decade

Marcel Verheij

244 papers receiving 13.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis

1996 1.6k citations Marcel Verheij et al. profile →
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2010 1.1k citations Marcel Verheij et al. profile →
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2016 1.1k citations Marcel Verheij et al. profile →
Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals

1995 741 citations Marcel Verheij et al. profile →
Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach

2013 377 citations Dirk De Ruysscher, Marcel Verheij et al. Radiotherapy and Oncology profile →

Peers

Countries citing papers authored by Marcel Verheij

Since Specialization

Citations

This map shows the geographic impact of Marcel Verheij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Verheij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Verheij more than expected).

Fields of papers citing papers by Marcel Verheij

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Verheij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Verheij. The network helps show where Marcel Verheij may publish in the future.

Co-authorship network of co-authors of Marcel Verheij

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Verheij. A scholar is included among the top collaborators of Marcel Verheij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Verheij. Marcel Verheij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The role of adjuvant chemotherapy in rectal cancer: A nationwide cohort study from the Netherlands 2025 ·Colorectal Disease ·(unknown), Tijmen Koëter, Felice N. van Erning, Robbert J. van Alphen, Henk M.W. Verheul, Marcel Verheij, D. D. E. Zimmerman, Pauline A. J. Vissers, Johannes H. W. de Wilt	1
2	Histopathological response to chemotherapy and survival of mucinous type gastric cancer 2024 ·JNCI Journal of the National Cancer Institute ·(unknown), (unknown), Pauline A. J. Vissers, (unknown), Laurens V. Beerepoot, Jelle P. Ruurda, Grard A. P. Nieuwenhuijzen, Suzanne S. Gisbertz, Mark I. van Berge Henegouwen, Henk H. Hartgrink, (unknown), Liudmila L. Kodach, Johanna W. van Sandick, Marcel Verheij, Rob H.A. Verhoeven, Annemieke Cats, Nicole C.T. van Grieken	0
3	Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective Cohort Study 2023 ·Annals of Surgical Oncology ·(unknown), (unknown), Felice N. van Erning, Marcel Verheij, Cornelis Verhoef, Johannes H. W. de Wilt, Pauline A. J. Vissers, Tijmen Koëter	13
4	The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer 2023 ·Journal of Gastroenterology ·(unknown), (unknown), Peter D. Siersema, Camiel Rosman, Nicole C.T. van Grieken, Mark I. van Berge Henegouwen, Johanna W. van Sandick, Marcel Verheij, Maarten F. Bijlsma, Rob H.A. Verhoeven, Hanneke W. M. van Laarhoven	7
5	Nationwide evaluation of pancreatic cancer networks ten years after the centralization of pancreatic surgery 2023 ·HPB ·(unknown), Lois A. Daamen, Gijs A. Patijn, Judith de Vos‐Geelen, Sebastiaan Festen, Bert A. Bonsing, Marcel Verheij, John J. Hermans, Marco J. Bruno, Roeland F. de Wilde, Ignace H. J. T. de Hingh, Marc G. Besselink, Kees J.H.M. van Laarhoven, Martijn W.J. Stommel	0
6	The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial 2023 ·Journal of Surgical Oncology ·(unknown), (unknown), Pehr Lind, Karolina Sikorska, (unknown), Fredrik Pontén, Marianne Nordsmark, Cornelis J.�H. van de Velde, Elma Meershoek‐Klein Kranenbarg, Johanna W. van Sandick, Edwin P. M. Jansen, Hanneke W.M. van Laarhoven, Marcel Verheij, Nicole C.T. van Grieken, Annemieke Cats	0
7	Implementation of MR-linac and proton therapy in two radiotherapy departments in The Netherlands: Recommendations based on lessons learned 2021 ·Radiotherapy and Oncology ·Maria Jacobs, Linda G.W. Kerkmeijer, Dirk De Ruysscher, Ellen Brunenberg, Liesbeth Boersma, Marcel Verheij	6
8	Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer 2020 ·Clinical Cancer Research ·(unknown), Michel M. van den Heuvel, Judi van Diessen, Heike Peulen, Erik van Werkhoven, Adrianus J. de Langen, Ferry Lalezari, Dick Pluim, Manon Verwijs-Janssen, Conchita Vens, Jan H.M. Schellens, Neeltje Steeghs, Marcel Verheij, Baukelien van Triest	39
9	A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapy 2020 ·EJNMMI Physics ·(unknown), Steffie M. B. Peters, Michelle W. J. Versleijen, (unknown), Marcel Verheij, Michiel Sinaasappel, Marcel P. M. Stokkel, Berlinda J. de Wit–van der Veen	16
10	Drug Sensitivity Prediction Models Reveal a Link between DNA Repair Defects and Poor Prognosis in HNSCC 2019 ·Cancer Research ·Paul Essers, (unknown), Caroline V.M. Verhagen, (unknown), Reinout H. de Roest, C. René Leemans, Ruud H. Brakenhoff, Michiel W. M. van den Brekel, Harry Bartelink, Marcel Verheij, Conchita Vens	13
11	Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity 2019 ·Cancer Immunology Research ·Paula Kroon, (unknown), (unknown), (unknown), Marit M. van Buuren, Ton N. Schumacher, Marcel Verheij, Jannie Borst, Inge Verbrugge	41
12	Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation 2019 ·European Archives of Oto-Rhino-Laryngology ·Joris B.W. Elbers, Lars I. Veldhuis, Patrick A. Bhairosing, Ludi E. Smeele, Katarzyna Jóźwiak, Michiel W. M. van den Brekel, Marcel Verheij, (unknown), Charlotte L. Zuur	34
13	Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer 2019 ·British journal of surgery ·(unknown), Francine E.M. Voncken, Jolanda M. van Dieren, Doenja M. J. Lambregts, Monique Maas, Gert J. Meijer, Lucas Goense, Stella Mook, Koen J. Hartemink, Pétur Snæbjörnsson, Leon C. ter Beek, Marcel Verheij, Berthe M.P. Aleman, Regina G. H. Beets‐Tan, Annemarieke Bartels‐Rutten	23
14	Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective 2016 ·Radiation Oncology ·(unknown), Christos Melidis, Jan‐Jakob Sonke, Sonja Adebahr, Ronald Boellaard, Marcel Verheij, Matthias Gückenberger, Ursula Nestle, Coen Hurkmans	28
15	Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients 2015 ·Clinical Cancer Research ·Monique C. de Jong, Jelle J. ten Hoeve, Reidar Grénman, Lodewyk F.A. Wessels, (unknown), Hein te Riele, Michiel W. M. van den Brekel, Marcel Verheij, Adrian C. Begg	63
16	Emerging issues in multimodality treatment of gastric cancer 2015 ·Anouk Kirsten Trip, Marcel Verheij, Johanna W. van Sandick, Henk Boot, Edwin P. M. Jansen, Annemieke Cats	1
17	Gezamenlijke besluitvorming steeds belangrijker 2015 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·Marcel Verheij, N.K. Aaronson	0
18	Combining Radiotherapy with APO010 in Cancer Treatment 2009 ·Clinical Cancer Research ·Inge Verbrugge, (unknown), Rogier W. Rooswinkel, Johan Jongsma, Nicola Beltraminelli, Marc Dupuis, Jannie Borst, Marcel Verheij	23
19	Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy 2007 ·British Journal of Cancer ·Edwin P. M. Jansen, Henk Boot, R. Dubbelman, Harry Bartelink, Annemieke Cats, Marcel Verheij	22
20	High Response Rates and Lasting Remissions After Low-Dose Involved Field Radiotherapy in Indolent Lymphomas 2003 ·Journal of Clinical Oncology ·Rick L. Haas, P Poortmans, Daphne de Jong, Berthe M.P. Aleman, L. Dewit, Marcel Verheij, A.A.M. Hart, Marinus H. J. van Oers, M. van der Hulst, (unknown), Harry Bartelink	119

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact